Therapeutic strategies, including anti-vascular endothelial growth factor (VEGF) therapy, photocoagulation, and vitrectomy, have been widely used to treat vision-threatening DR, e.g., proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME). This evidence concerns the gene VEGFA and diabetic macular edema.